Inactive von Hippel-Lindau (VHL) is an important factor in the pathogenesis of clear cell renal cell carcinoma (ccRCC), which exerts oncogenic effects by inducing histone lactylation to activate platelet-derived growth factor receptor beta (PDGFRβ) expression. Here, PDGFRB is linked to clear cell renal carcinoma.